Member Login
  1. Stocks
    2. /
  2. Dechra Pharmaceuticals PLC (LSE: DPH)
    3. /

LSE:DPH (Dechra Pharmaceuticals PLC)

About DPH

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. It listed in London in 2000.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Dechra Pharmaceuticals PLC (LSE: DPH) Latest News

    Investing Articles

    This FTSE 250 dog might be a stonking contrarian pick

    | Paul Summers

    Today's trading update suggests investors are being far too negative on this FTSE 250 (INDEXFTSE:MCX) stock.

    Read more »

    Investing Articles

    2 surprising growth stocks that could help you retire early

    | Peter Stephens

    These two shares may offer higher growth rates than expected.

    Read more »

    Investing Articles

    These great growth stocks have much further to go

    | Royston Wild

    Royston Wild looks at two stocks with hot earnings prospects.

    Read more »

    Investing Articles

    One growth stock I’d buy — and one I’d sell — right now

    | Royston Wild

    Royston Wild discusses two growth stocks with very different near-term outlooks.

    Read more »

    Investing Articles

    Enjoy double-digit earnings growth with these FTSE 250 stars

    | Royston Wild

    Royston Wild looks at three FTSE 250 (INDEXFTSE: MCX) stocks with spectacular earnings potential.

    Read more »

    Investing Articles

    Why I’m avoiding these exciting growth shares right now

    | Bilaal Mohamed

    Bilaal Mohamed explains why investors should wait before buying these growth stocks.

    Read more »

    Investing Articles

    Should you make room for Pets At Home Group plc after today’s update?

    | Paul Summers

    The market may not like today's update but Paul Summers thinks Pets At Home Group plc (LON:PETS) is a sound…

    Read more »

    Investing Articles

    Does this pharma’s 56% sales growth make it a better buy than GlaxoSmithKline plc?

    | Peter Stephens

    Should you sell GlaxoSmithKline plc (LON: GSK) and pile into this hot pharma stock?

    Read more »

    Investing Articles

    4 growth stocks to put on your 2017 shopping list

    | Royston Wild

    Royston Wild runs the rule over some of London’s hottest growth stocks.

    Read more »

    Investing Articles

    Could these top-performing stocks be about to collapse?

    | Bilaal Mohamed

    Bilaal Mohamed considers whether these shares are heading for a correction after this year's spectacular gains.

    Read more »

    Investing Articles

    2 shining pharmaceuticals stars to challenge the big guns?

    | Alan Oscroft

    Can these smaller upstarts beat the champions at their own game?

    Read more »

    Investing Articles

    Is Dechra Pharmaceuticals plc a better buy than GlaxoSmithKline plc after today’s news?

    | Royston Wild

    Royston Wild weighs up the investment potential of drugs deities Dechra Pharmaceuticals plc (LON: DPH) and GlaxoSmithKline plc (LON: GSK).

    Read more »